In this study, the survival prognosis of patients with USH2A mutations was poor; however, in the USH2A mutant tumor samples, there was an enrichment of activated NK cells, TFH cells, and γδ T cells, indicating a change in the recognition of immune surveillance, as well as an antitumor effect. Here, USH2A is linked to neoplasm.